Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Tiago M. Bondea Department of Urology, Ryhov Hospital, Jönköping, SwedenCorrespondence[email protected]
View further author information

Hans Garmob Department of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information

Pär Stattinb Department of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information

Per Nilssonc Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden

Adalsteinn Gunnlaugssonc Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, SwedenView further author information

Daniela Swanbergd Department of Surgery, Höglandssjukhuset, Eksjö, SwedenView further author information

David Robinsone Department of Urology, Höglandssjukhuset, Eksjö, SwedenView further author information

Your download is now in progress and you may close this window